0001209191-23-056412.txt : 20231122 0001209191-23-056412.hdr.sgml : 20231122 20231122071844 ACCESSION NUMBER: 0001209191-23-056412 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231120 FILED AS OF DATE: 20231122 DATE AS OF CHANGE: 20231122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fox Christine CENTRAL INDEX KEY: 0001998173 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16174 FILM NUMBER: 231429962 MAIL ADDRESS: STREET 1: C/O TEVA STREET 2: 5 BASEL STREET, P.O. BOX 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 4951033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000818686 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 BAZEL ST STREET 2: P O B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 BUSINESS PHONE: 9729267267 MAIL ADDRESS: STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED STREET 2: 5 BAZEL ST PO B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-20 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001998173 Fox Christine C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A STREET TEL AVIV L3 6944020 ISRAEL 0 1 0 0 EVP, Head of U.S. Commercial 0 Restricted Share Units 2023-11-20 4 A 0 253968 0.00 A Ordinary Shares 253968 253968 D Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on November 20, 2023, with 63,492 vesting on each of November 20, 2024, November 20, 2025, November 20, 2026 and November 20, 2027. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. /s/ Dov Bergwerk as attorney-in-fact for Christine Fox 2023-11-22